ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,655.50
4.50 (0.27%)
Last Updated: 12:23:29
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  4.50 0.27% 1,655.50 1,655.00 1,656.00 1,661.50 1,650.00 1,656.50 706,950 12:23:29
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.81 68.05B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,651p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £68.05 billion. Gsk has a price to earnings ratio (PE ratio) of 13.81.

Gsk Share Discussion Threads

Showing 19926 to 19948 of 33100 messages
Chat Pages: Latest  808  807  806  805  804  803  802  801  800  799  798  797  Older
DateSubjectAuthorDiscuss
27/8/2019
08:50
All the gains made on the good news have now evaporated
abdullla
23/8/2019
10:02
Good news.

"GlaxoSmithKline was in the green after the pharmaceuticals giant said a clinical trial of its blood cancer treatment met its primary goal."

Morning everyone.

philanderer
23/8/2019
08:58
Bailed out. No easy route back in.Lots of patience required now.
xxxxxy
23/8/2019
08:41
Right now, 1650p looks attractive!
tradermichael
23/8/2019
08:30
TM,what do you think the bargain price is
abdullla
23/8/2019
08:14
Too much good news about to get a bargain price at the moment:

GlaxoSmithKline PLC (GSK.LN) said Friday that headline results from its DREAMM-2 study for treatment of multiple myeloma, a type of blood cancer, were positive.
The pharmaceutical company said the two-arm study of its treatment belantamab mafodotin met its primary objective and demonstrated a clinically meaningful overall response rate.
Safety and tolerability was consistent with that observed in the DREAMM-1 study, GlaxoSmithKline said.
Data from the DREAMM-2 study will be the basis for regulatory filings starting later this year, the company said. Belantamab mafodotin is on track for regulatory submission by the end of 2019, it said.

tradermichael
23/8/2019
08:03
Buy now or you miss the train
abdullla
22/8/2019
17:08
No-one buying anywhere
prambigear
22/8/2019
09:26
GSK going up but no one buying here
abdullla
21/8/2019
11:18
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the submission of a Japanese New Drug Application (JNDA) to the Ministry of Health, Labour and Welfare seeking marketing approval for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the treatment of patients with renal anaemia due to chronic kidney disease (CKD).

Dr Hal Barron, Chief Scientific Officer and President R&D, GSK said, “Around 3.5 million patients in Japan have anaemia associated with renal disease which can result in weakness and fatigue. We are excited about our first regulatory filing for daprodustat which, if approved, will provide a new and convenient oral treatment option for these patients.”

tradermichael
20/8/2019
09:23
Dial 1700 for a £1 profit going long, imv!
(I'm not a short term trader 'tho).

sogoesit
20/8/2019
09:05
Fatal also could mean dial 999 :)
abdullla
20/8/2019
08:57
"Fatal"?
See your Risk Management Manual, please.
;-)

sogoesit
20/8/2019
08:30
TM,with the GSK share price shooting up daily what is the future entry point for those having sold and now sitting on the cash,re-entry at this point of time could be fatal?
abdullla
18/8/2019
13:27
Some divis coming my way next week (RIO).
Looks like this a good candidate for accumulation.

sogoesit
16/8/2019
09:58
Thanks for info TM :-)
sicker
16/8/2019
09:22
Breaking: FTSE trading should partially re-commence at 10:10am
The LSE says:
All GTD orders on partition 1 and 2 have been expired.
Instruments on partition 1 and 2 will resume in an opening auction call at 09:20 and will uncross at 09:40. EDSP auction for FTSE100 securities will commence as per today’s standard schedule at 10:10. Users that receive rejection messages, are advised to log out their trading sessions and log back on to the relevant gateways again.

tradermichael
16/8/2019
09:18
Technical glitches have been blamed for previous outages with investors last left in limbo by a four-hour delay to trading in 2011, after the LSE switched from its Turquoise system to a new platform called MillenniumIT. The shutdown came on the new system's 10th day of operation.
tradermichael
16/8/2019
09:00
Looking to buy in below 16.40 to add to those I already have. I'm heavy in GSK but did buy some RDSB and LGEN yesterday. Income is key for me but will take advantage of ranges when I'm confident to do so.
aimtoretire
16/8/2019
08:33
Yes,

London Stock Exchange delays open of top indexes after “potential trading services issue” is discovered

tradermichael
16/8/2019
08:32
Cant trade either on ii so looks like a market issue
phda
16/8/2019
08:31
Anybody see any prices this morning? My screens show no live data??
tradermichael
15/8/2019
11:25
Next week I reckon.
iknowverylittle
Chat Pages: Latest  808  807  806  805  804  803  802  801  800  799  798  797  Older

Your Recent History

Delayed Upgrade Clock